Skip to content

Author

K. Iwatani

We have 2 of 144 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Oncological Outcomes and Safety Profiles of Adjuvant Nivolumab in Muscle‐Invasive Urothelial Carcinoma

Perioperative immunotherapy has become the standard of care in patients with high‐risk muscle‐invasive urothelial carcinoma (MIUC). This study aimed to clarify oncological outcomes and safety profiles of adjuvant nivolumab therapy in MIUC, focusing on upper tract urothelial carcinoma (UTUC).

Satoshi Katayama, Tatsushi Kawada, K. Mori et al. · 1 citation
Open access Sep 2026

Perioperative Safety and Long‐Term Oncological Outcomes of En Bloc Resection of Bladder Tumor: A Multicenter Real‐World Study of 668 Patients

To evaluate perioperative safety, pathological outcomes, and oncological outcomes of en bloc resection of bladder tumor (ERBT) in a large multicenter real‐world cohort.

T. Yanagisawa, A. Matsukawa, K. Iwatani et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.